Vernalis steps up in size, could move to AIM
Vernalis, a speciality drugs firm, raised £68.5m from a placing and open offer on Friday in a deal that is likely to see it move from London’s main market to the Alternative Investment Market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts